Pilgrim's Pride Q2 Earnings Collapse: Net Income Down 96%, U.S. Segment Swings to Loss
PPC is trading near its 52-week low of $26.5 (11% above the low).
Summary
Pilgrim's Pride Q2 net income collapsed 96% to $13.2M as weak chicken prices and massive litigation costs crushed margins. The U.S. segment swung to an operating loss.
Key Events · Earnings and Guidance · PPC
-
Q2 Net Income Collapses 96%
Net income attributable to Pilgrim's Pride fell to $13.4M from $355.5M a year ago, with GAAP EPS of $0.06 missing expectations. Revenue slipped 2.8% to $4.63B.
-
U.S. Segment Swings to Operating Loss
The U.S. segment posted an operating loss of $11.1M compared to a $355.0M profit in Q2 2025, driven by lower chicken prices and a 55% surge in SG&A expenses tied to legal costs.
-
Litigation Costs Drain Earnings
Litigation settlements consumed $155.4M in H1 2026, with total broiler antitrust costs reaching $838.5M. The company continues to defend against opt-out plaintiffs and seek settlements.
-
Asset Impairments and Restructuring
The company recorded $22.3M in asset impairment charges for the closure of a Chattanooga plant and equipment replacement in Russellville, AL. Europe restructuring charges added $8.7M.
Analysis · PPC · Manufacturing
Pilgrim's Pride's Q2 2026 results reveal a severe earnings collapse. Net income plunged 96% to just $13.2 million, driven by a 25% drop in commodity chicken prices and a staggering $135.7 million in litigation settlements. The U.S. segment, the company's core, swung from a $355 million profit to an $11 million operating loss. SG&A costs ballooned 55% in the U.S. as legal defense costs mounted. The company has now spent $838.5 million on broiler antitrust litigation, with no end in sight. While the new European credit facility provides liquidity, the near-term earnings power of the business is severely impaired, and the litigation overhang continues to drain cash.
At the time of this filing, PPC was trading at $29.51 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $7.1B. The 52-week trading range was $26.50 to $50.56. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.